| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8962290 | Vaccine | 2018 | 7 Pages |
Abstract
The dominant circulating strain during the Indonesian Phase IIb efficacy trial of the RV3-BB vaccine was an equine-like G3P[8] strain. The equine-like G3P[8] strain is an emerging cause of severe gastroenteritis in Indonesia and in other regions.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Daniel Cowley, Hera Nirwati, Celeste M. Donato, Nada Bogdanovic-Sakran, Karen Boniface, Carl D. Kirkwood, Julie E. Bines,